|
Resolution: standard / high Figure 7.
MMP-2/laminin-5 in mammary glands of adult wild-type and PR-A mice; laminin immunostaining
in PR-B transgenics. In situ localization of MMP-2 and laminin-5 in mammary glands of adult wild-type (WT) and
PR-A transgenics, and laminin staining in PR-B transgenics. (a) MMP-2 and laminin-5 were detected in fixed frozen sections of mammary glands, using
an indirect immunofluorescence assay, as described in the text. Blue, 4',6-diamino-2-phenylindole
(DAPI) staining of the nuclei; green, fluorescein isothiocyanate staining corresponding
to immunoreactive latent MMP-2; red, Texas Red staining corresponding to immunoreactive
laminin-5. Staining in glands from WT mice and in normal structures derived from PR-A
mice showed continuous laminin-5 staining and the presence of MMP-2 in the periepithelial
stroma. In aberrant structures derived from glands of PR-A transgenic mice, however,
staining for both laminin-5 and latent MMP-2 was lost (right panels). Top left, mammary
duct from wild-type mouse; bottom left, normal duct from PR-A transgenic mouse; top
right, duct from PR-A transgenic mouse containing both normal and morphogenetically
disturbed epithelium; bottom left, aberrant structure in PR-A transgenic mouse. (b) Laminin staining (green) in a mammary gland derived from a PR-B transgenic mouse shows
that it circumscribes the epithelium as in the WT control. Nuclei were counterstained
with DAPI (blue).
Simian et al. Breast Cancer Research 2009 11:R72 doi:10.1186/bcr2408 |